Richard W. Price

30.0k total citations · 10 hit papers
260 papers, 20.0k citations indexed

About

Richard W. Price is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Richard W. Price has authored 260 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Virology, 139 papers in Infectious Diseases and 80 papers in Emergency Medicine. Recurrent topics in Richard W. Price's work include HIV Research and Treatment (187 papers), HIV/AIDS Research and Interventions (110 papers) and HIV-related health complications and treatments (80 papers). Richard W. Price is often cited by papers focused on HIV Research and Treatment (187 papers), HIV/AIDS Research and Interventions (110 papers) and HIV-related health complications and treatments (80 papers). Richard W. Price collaborates with scholars based in United States, Sweden and United Kingdom. Richard W. Price's co-authors include Bradford Navia, Bruce J. Brew, Magnus Gisslén, Serena Spudich, Carol K. Petito, Barry Jordan, John J. Sidtis, Eun‐Sook Cho, Lars Hagberg and Dietmar Fuchs and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Richard W. Price

254 papers receiving 19.3k citations

Hit Papers

The AIDS dementia complex: I. Clinical features 1985 2026 1998 2012 1986 1988 1988 1986 1985 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard W. Price United States 73 13.6k 8.5k 5.0k 4.6k 3.2k 260 20.0k
Bruce J. Brew Australia 75 8.7k 0.6× 5.1k 0.6× 2.5k 0.5× 3.7k 0.8× 3.7k 1.1× 321 19.5k
Ronald J. Ellis United States 71 11.5k 0.8× 7.3k 0.9× 2.9k 0.6× 5.9k 1.3× 2.9k 0.9× 414 18.1k
Justin C. McArthur United States 100 16.4k 1.2× 8.8k 1.0× 4.8k 1.0× 6.2k 1.3× 5.0k 1.6× 337 29.9k
Avindra Nath United States 89 11.3k 0.8× 3.9k 0.5× 3.1k 0.6× 2.3k 0.5× 5.4k 1.7× 434 23.9k
Susan Morgello United States 66 5.6k 0.4× 3.3k 0.4× 2.4k 0.5× 2.9k 0.6× 2.3k 0.7× 275 13.3k
Leon G. Epstein United States 55 6.1k 0.4× 3.6k 0.4× 2.8k 0.6× 1.5k 0.3× 1.8k 0.6× 187 10.8k
Howard E. Gendelman United States 97 17.3k 1.3× 8.6k 1.0× 4.9k 1.0× 2.5k 0.5× 9.1k 2.8× 495 36.4k
Dana Gabuzda United States 67 8.8k 0.6× 4.5k 0.5× 2.5k 0.5× 1.3k 0.3× 1.6k 0.5× 152 13.3k
Andrew A. Lackner United States 70 8.7k 0.6× 6.1k 0.7× 4.6k 0.9× 1.1k 0.2× 1.5k 0.5× 261 17.3k
Bradford Navia United States 49 6.2k 0.5× 3.2k 0.4× 2.2k 0.4× 2.3k 0.5× 1.4k 0.4× 102 9.3k

Countries citing papers authored by Richard W. Price

Since Specialization
Citations

This map shows the geographic impact of Richard W. Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard W. Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard W. Price more than expected).

Fields of papers citing papers by Richard W. Price

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard W. Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard W. Price. The network helps show where Richard W. Price may publish in the future.

Co-authorship network of co-authors of Richard W. Price

This figure shows the co-authorship network connecting the top 25 collaborators of Richard W. Price. A scholar is included among the top collaborators of Richard W. Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard W. Price. Richard W. Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ripamonti, Enrico, Magnus Gisslén, Lars Hagberg, et al.. (2025). Cerebrospinal fluid biomarkers associated with neurofilament light levels: A study in HIV disease. Journal of Neuroimmunology. 400. 578521–578521. 1 indexed citations
2.
Kincer, Laura P., Ameet Dravid, Mattia Trunfio, et al.. (2024). Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation. Journal of Clinical Investigation. 134(19). 6 indexed citations
3.
Hawes, Isobel A., Bonny D. Alvarenga, Anne E. Wapniarski, et al.. (2023). Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape. Journal of Neuroimmunology. 381. 578141–578141. 5 indexed citations
4.
Meyer, Ana‐Claire, Alfred K. Njamnshi, Magnus Gisslén, & Richard W. Price. (2022). Neuroimmunology of CNS HIV Infection: A Narrative Review. Frontiers in Neurology. 13. 843801–843801. 7 indexed citations
5.
Price, Richard W., Magnus Gisslén, Henrik Zetterberg, et al.. (2022). Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection. HIV Medicine. 24(4). 442–452. 6 indexed citations
6.
Gisslén, Magnus, Sheila M. Keating, Serena Spudich, et al.. (2021). Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression. PLoS ONE. 16(5). e0250987–e0250987. 37 indexed citations
7.
Hagberg, Lars, Richard W. Price, Henrik Zetterberg, Dietmar Fuchs, & Magnus Gisslén. (2020). Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance. PLoS ONE. 15(7). e0236162–e0236162. 13 indexed citations
8.
Yilmaz, Aylin, Dietmar Fuchs, Richard W. Price, et al.. (2019). Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders. Current HIV/AIDS Reports. 16(1). 76–81. 9 indexed citations
9.
Farhadian, Shelli, Sameet Mehta, Chrysoula Zografou, et al.. (2018). Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV. JCI Insight. 3(18). 79 indexed citations
10.
Edén, Arvid, Thomas D. Marcotte, Robert K. Heaton, et al.. (2016). Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS ONE. 11(6). e0157160–e0157160. 84 indexed citations
11.
Lee, Evelyn, Julia Peterson, Bridget McLaughlin, et al.. (2016). Immune Activation and HIV-Specific CD8 + T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. AIDS Research and Human Retroviruses. 32(8). 791–800. 11 indexed citations
12.
Chow, Felicia C., W. John Boscardin, Claire Mills, et al.. (2015). Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals. AIDS. 30(1). 45–55. 20 indexed citations
13.
Gisslén, Magnus, Richard W. Price, & Staffan Nilsson. (2011). The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?. BMC Infectious Diseases. 11(1). 356–356. 178 indexed citations
14.
Yilmaz, Aylin, Richard W. Price, Patrick Mallon, et al.. (2009). Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1–Infected Individuals. AIDS Research and Human Retroviruses. 25(4). 457–461. 70 indexed citations
15.
Raftopoulos, Spiro, George Garas, Richard W. Price, et al.. (2006). Epstein-Barr virus–associated cholangiopathy: a new disease entity?. Gastrointestinal Endoscopy. 63(1). 172–176. 1 indexed citations
16.
Cysique, Lucette A., Bruce J. Brew, Mark Halman, et al.. (2005). Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(4). 426–429. 44 indexed citations
17.
Price, Richard W. & Steven G. Deeks. (2004). Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system. Journal of NeuroVirology. 10(1). 44–51. 25 indexed citations
18.
Price, Richard W., Constantin T. Yiannoutsos, Lawrence Zaborski, et al.. (1999). Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS. 13(13). 1677–1685. 111 indexed citations
19.
Heyes, Melvyn P., Bruce J. Brew, Alex Martin, et al.. (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status. Annals of Neurology. 29(2). 202–209. 479 indexed citations breakdown →
20.
Epstein, Leon G., et al.. (1983). HTLV-III/LAV-LIKE RETROVIRUS PARTICLES IN THE BRAINS OF PATIENTS WITH AIDS ENCEPHALOPATHY. PubMed. 1(6). 447–454. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026